Discontinuing a statin in over-65s poses a significant risk for fatal and nonfatal cardiovascular events, Italian researchers say.

“Polypharmacy is a major health concern among older adults. While deprescribing may reduce inappropriate medicine use, its effect on clinical end points remains uncertain,” write Dr Annalisa Biffi of the University of Milano-Bicocca and colleagues.